Courts and prosecutors have a frontline role to play in the fight against the opioid epidemic, but don’t expect high-ranked officials from Big Pharma to face criminal prosecution any time soon, a group of criminal justice officials from across the country said during a panel discussion March 16.

“I wouldn’t get anyone’s hopes up, There’s just a host of problems,” New York City’s Special Narcotics Prosecutor Bridget Brennan told the audience, adding that statute of limitations issues might be the biggest hurdle in prosecuting pharmaceutical executives.